title: Feasibility, reliability and validity of the Chinese simplified version of the MOS-HIV health survey among AIDS patients in China.
abstract: OBJECTIVE
  To test the feasibility, reliability and validity of the Chinese simplified version of the MOS-HIV health survey among AIDS patients in China.
  
  
  METHODS
  A cross-sectional survey of 120 patients receiving highly active antiretroviral treatment was conducted. Feasibility was assessed using the time of administration and the response rate. Reliability was estimated using Cronbach's α. Validity was analyzed by construct and discriminant validity.
  
  
  RESULTS
  The time of administration was about 12 min, and the response rate was 100%. The MOS-HIV showed a good internal reliability and Cronbach's α of eight multi-item scales ranged from 0.75 to 0.91. Correlations between scales were all significant. The majority of the correlations between pairs of scales were within the acceptable range (0.4-0.8). The scores of role function, pain, physical health summary scales were significantly higher for patients with time on antiretroviral treatment >1 year compared to those with time ≤ 1 year. Patients >40 years had significantly higher scores than those of ≤ 40 years on energy and mental health summary scales.
  
  
  CONCLUSIONS
  The Chinese simplified version of MOS-HIV health survey had good feasibility, reliability and validity. It was successfully adapted for AIDS patients in rural areas and could be a valuable tool in evaluating the quality of life of AIDS patients.
authors.affiliation: Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, 230032, Anhui, People's Republic of China.
authors.forename: Zhang-Jun
authors.initials: ZJ
authors.lastname: Huang
authors.forename: Min
authors.initials: M
authors.lastname: Tian
authors.forename: Se-Ying
authors.initials: SY
authors.lastname: Dai
authors.forename: Dong-Qing
authors.initials: DQ
authors.lastname: Ye
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D044466:Asian People / Q000523:psychology*; D002681:China; D003430:Cross-Sectional Studies; D005240:Feasibility Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000523:psychology*; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care / Q000379:methods*; D011594:Psychometrics / Q000295:instrumentation*; D011788:Quality of Life / Q000523:psychology*; D015203:Reproducibility of Results; D018434:Sickness Impact Profile; D012959:Socioeconomic Factors
chemical_list: D044966:Anti-Retroviral Agents